IOL CHEMICALS & PHARM. | CHEMO PHARMA | IOL CHEMICALS & PHARM./ CHEMO PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 9.4 | 145.5% | View Chart |
P/BV | x | 1.6 | 1.1 | 142.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. CHEMO PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
CHEMO PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ CHEMO PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 49 | 1,093.1% | |
Low | Rs | 272 | 29 | 930.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 0 | - | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.3 | 7,563.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.4 | 7,890.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 77.3 | 332.0% | |
Shares outstanding (eoy) | m | 58.71 | 1.50 | 3,914.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0 | - | |
Avg P/E ratio | x | 17.1 | 124.4 | 13.7% | |
P/CF ratio (eoy) | x | 12.8 | 97.1 | 13.2% | |
Price / Book Value ratio | x | 1.6 | 0.5 | 310.9% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 59 | 40,405.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1 | 258,784.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 0 | - | |
Other income | Rs m | 256 | 7 | 3,602.0% | |
Total revenues | Rs m | 22,427 | 7 | 315,431.8% | |
Gross profit | Rs m | 2,257 | -6 | -36,934.5% | |
Depreciation | Rs m | 462 | 0 | 355,076.9% | |
Interest | Rs m | 165 | 0 | 126,692.3% | |
Profit before tax | Rs m | 1,887 | 1 | 258,424.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | 190,423.1% | |
Profit after tax | Rs m | 1,391 | 0 | 296,042.6% | |
Gross profit margin | % | 10.2 | 0 | - | |
Effective tax rate | % | 26.2 | 35.5 | 74.0% | |
Net profit margin | % | 6.3 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 61 | 15,774.3% | |
Current liabilities | Rs m | 5,025 | 0 | 2,512,600.0% | |
Net working cap to sales | % | 20.9 | 0 | - | |
Current ratio | x | 1.9 | 306.4 | 0.6% | |
Inventory Days | Days | 43 | 0 | - | |
Debtors Days | Days | 8 | 0 | - | |
Net fixed assets | Rs m | 11,017 | 53 | 20,977.5% | |
Share capital | Rs m | 587 | 15 | 3,914.0% | |
"Free" reserves | Rs m | 14,490 | 101 | 14,343.8% | |
Net worth | Rs m | 15,077 | 116 | 12,995.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 114 | 18,175.7% | |
Interest coverage | x | 12.5 | 6.6 | 188.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0 | - | |
Return on assets | % | 7.5 | 0.5 | 1,420.0% | |
Return on equity | % | 9.2 | 0.4 | 2,263.6% | |
Return on capital | % | 13.6 | 0.7 | 1,831.3% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -7 | -17,901.9% | |
From Investments | Rs m | -1,200 | 6 | -19,047.6% | |
From Financial Activity | Rs m | -41 | -1 | 5,407.9% | |
Net Cashflow | Rs m | -18 | -1 | 1,415.4% |
Indian Promoters | % | 48.2 | 27.9 | 172.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.2 | 1,000.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 72.1 | 71.8% | |
Shareholders | 130,003 | 6,262 | 2,076.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | CHEMO PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.14% | -1.01% | -0.33% |
1-Month | 5.68% | 23.58% | -0.42% |
1-Year | -2.26% | 121.95% | 53.28% |
3-Year CAGR | -12.99% | 40.82% | 14.79% |
5-Year CAGR | 17.41% | 57.69% | 19.71% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the CHEMO PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of CHEMO PHARMA the stake stands at 27.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of CHEMO PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
CHEMO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of CHEMO PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.